Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 13, 2020

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions

Becker Muscular Dystrophy

Interventions

DRUG

(+)-Epicatechin

(+)-Epicatechin is a synthetic flavanol

Trial Locations (3)

Washington University School of Medicine, St Louis

UCLA Dept of Human Genetics, Los Angeles

University of California - Davis Department of Physical Medicine and Rehabilitation, Sacramento